Carregant...
Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial
BACKGROUND: Anti-inflammatory treatment with interleukin-1 (IL-1) antagonism decreases both cortisol and adrenocorticotropin hormone (ACTH) levels in individuals with obesity in short term. However, it remains unknown whether these effects persist upon prolonged treatment. METHODS: In this double-bl...
Guardat en:
| Publicat a: | Endocr Connect |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Bioscientifica Ltd
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6547405/ https://ncbi.nlm.nih.gov/pubmed/31042669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-19-0201 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|